On May 12, 2025 Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology, reported that management will participate in the following investor conferences (Press release, Tyra Biosciences, MAY 12, 2025, View Source [SID1234652898]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Bank of America Global Healthcare Conference, May 13-15, 2025
Format: Fireside chat and one-on-one investor meetings
Presentation Date/Time: Tuesday, May 13, 2025, at 5:15 PM PT
Location: Las Vegas, NV

Jefferies Global Healthcare Conference, June 3-5, 2025
Format: One-on-one investor meetings
Location: New York, NY

UBS Biotech 1×1 Symposium, June 24, 2025
Format: One-on-one investor meetings
Location: New York, NY

A live and archived webcast of the fireside chat will be available via the For Investors page on the Investor section of the TYRA website.